NCT/Study#
NCT04535557 /
MOBO-IZ2966-1
An expanded access program for mobocertinib in Non Small Cell Lung Cancer exon20 insertion mutation patients
DISEASE GROUP:
Thoracic (Lung)
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
